Worst News for Stocks in 50 Years

Wall Street’s declared what could be the worst news for the U.S. stock market in 50 years.

If Goldman Sachs and Morgan Stanley are right... this won't be like the crashes we're used to. What's about to hit America next could keep your portfolio in the red for 10 years or longer - unless you make a big change now. 

To hear about this decade-long crisis now being predicted by multiple Wall Street banks... 

And to see what you can do to prepare your wealth before this hits... 

Click here to learn how to defend your portfolio. 

Regards, 

Keith Kaplan
CEO, TradeSmith 

P.S. You may have noticed we see "surprise" crashes every year now. Think about it: rate spikes in 2022... the bank crisis in 2023... $8 trillion wiped out in 2024... $11 trillion wiped out during the tariff crash in 2025... and, this year, $12 trillion was wiped out in 30 days during the Iran War. Something is off and Wall Street suggests this could continue (and worsen) well into the 2030s. Click here to learn the truth about this market and see what you must do now to prepare.

From Industry Titans to Tiny Fish: 3 Key Stocks Insiders are Trading

Written by Leo Miller. Date Posted: 6/6/2026.

Insiders are making moves in both massive and minuscule stocks in Q2 2026, with MarketBeat tracking notable buys and sells across several interesting names. That includes one of the world’s biggest names in energy, a gene testing stock that surged more than 2,000% in 2024, and a company that some consider to be the most important in the world.

Chevron Insider Sells Over $100M as Oil Prices Retreat From Highs

Shares of oil giant Chevron (NYSE: CVX) have performed well in 2026, like many stocks in the oil industry. The conflict in the Middle East and the closure of  the Strait of Hormuz sent oil prices soaring, benefiting energy stocks. The Strait has seen intermittent increases in traffic since the conflict initially began, but it remains effectively closed, with traffic down sharply compared to pre-March levels.

Still, oil has come down meaningfully, with West Texas Intermediate crude down almost 20% from 2026 highs. Markets may be anticipating that a deal between the U.S. and Iran will eventually be reached, avoiding an all-out war that would cause longer-term oil disruptions. Chevron has pulled back as well, falling around 10% from its 2026 highs, but it is still up more than 20% on the year.

The stock also saw a large amount of insider selling in May, with MarketBeat tracking $109 million in sales. These sales were made by director John B. Hess and were not made under a predetermined 10b5-1 plan. Given the fact that oil prices are coming down, this is a moderately negative signal for Chevron. The stock may not be able to rely on further oil price increases to drive shares higher. However, it is worth noting that sales have actually come down versus Q1, when MarketBeat tracked $205 million worth of sales.

GeneDx Insiders Load Up After Massive Earnings Plunge

Next up is GeneDx (NASDAQ: WGS). The company provides genetic testing services, specializing in pediatrics and rare disease diagnostics. This small stock went ballistic in 2024, gaining just under 2,700%. It followed that up with a 69% gain in 2025. However, things have taken a turn for the worse in 2026, with shares now down more than 50% for the year.

Notably, its revenue growth rate has fallen from a peak near 67% year over year (YOY) to 17% YOY in its latest quarter. GeneDx shares dropped 49% after the company’s latest earnings report as it posted a $10 million miss on revenue and a 22-cent miss on loss per share. The company also lowered its full-year guidance, and GeneDx’s market capitalization now sits near $1.6 billion.

However, insiders have shown strong confidence in GeneDx since its post-earnings plunge. Overall, MarketBeat has tracked $82 million worth of insider buys in Q2, all of which came after its report. These purchases came from Director Keith A. Meister and Casdin Capital LLC. Meanwhile, MarketBeat has tracked just $167,000 worth of insider sales, which came before its earnings report. While these buys are positive indicators for GeneDx, the stock clearly remains a highly volatile and risky name.

TSMC Sees Buys and Sells as Shares Continue to Climb

Last up is a stock that is anything but small: Taiwan Semiconductor Manufacturing (NYSE: TSM). As the artificial intelligence (AI) buildout has continued to progress with few signs of slowing, TSMC shares keep chugging higher. Overall, the stock is up well more than 40% on the year, with TSMC now trading just below a $2 trillion market capitalization. TSMC now ranks among the world’s 10 most valuable publicly traded companies. With its dominance in advanced chip-making, many have called TSMC the world’s most important company.

TSMC’s last earnings report showed the company posting solid beats on sales and adjusted earnings per share. The company boosted its 2026 revenue growth guidance to over 30% YOY and increased its capital expenditure outlook, signaling long-term confidence.

Insiders are sending mixed signals around the stock. MarketBeat has tracked $14 million worth of insider sales in Q2, compared to $162,000 worth of insider purchases.

Notably, CEO Che-Chia Wei (C.C. Wei) was one of the individuals who purchased shares. Vice President Chuang Tzu-Sou was a seller, reducing his shares held by around 7%.

Overall, these insider trades amount to a neutral indicator. Despite insider sales being significantly higher than buys, sales are generally much less indicative of insider sentiment. Insiders often sell simply to gain liquidity, while buys signal direct confidence in a firm’s outlook.

Don’t Take Insider Trades as Gospel

While many of these trades send interesting signals to investors, it is important to note that they are just one of many factors to consider. As stated, sales do not necessarily mean an insider is bearish on a stock. Meanwhile, insiders who purchase shares can still be wrong about their company’s stock—especially in the near term.

A recent example of this surrounds apparel giant Nike (NYSE: NKE). CEO Elliott Hill made headlines at the end of 2025 when he bought $1 million worth of beaten-down Nike shares near $61. Nike has continued to fall sharply since then, now trading in the mid-$40s range.